Conference Roundup: CPDD 86th Annual Scientific Meeting

8:00 AM – 9:00 AM

Oral Session – Breaking Down Barriers: Addressing Disparities in Substance Use among Justice-Involved Populations

• Transitions of Care between Jail-Based Medications for Opioid Use Disorder and Ongoing Treatment in the Community: A Retrospective Cohort Study
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, oral session chair and oral presentation speaker
  • Sean M. Murphy, PhD, Weill Cornell Medicine, CHERISH Methodology Core Co-director and CHERISH Consultation Service Director, oral presentation co-author
  • Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Research Affiliate, oral presentation co-author

9:15 AM – 10:15 AM

Oral Session – Poutine the Treatment Where it Counts: Buprenorphine Induction Methods

• Buprenorphine Precipitated Withdrawal in Hospitalized Patients with Opioid Use Disorder: Incidence and Risk Factors from a Community with High Fentanyl Prevalence
  • Margaret Lowenstein, MD, MSHP, University of Pennsylvania Perelman School of Medicine, CHERISH Dissemination & Policy Core Co-director, oral presentation co-author

Oral Session – Impact of Recent Trauma on Drug Use

• Association of Recent Traumatic Brain Injury with Subsequent Nonfatal Overdose among People Who Use Drugs in Vancouver, British Columbia, 2018 – 2020
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH Population Data & Modeling Core Investigator, oral presentation co-author

3:45 PM – 4:45 PM

Oral Session – Built to Last? Long-Acting Formulations Use Disorders

• An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH Population Data & Modeling Core Investigator, oral presentation co-author

Oral Session – Exploring the Parent-Child Dyad: Reciprocal Influences and Their Impact on Drug Use and Other Related Outcomes

• Untreated Substance Use Disorders among Caregivers with Children Reported to Child Protective Services
  • Tami L. Mark, PhD, MBA, RTI International, CHERISH Research Affiliate, oral session chair and oral presentation speaker

5:30 PM – 7:00 PM

Poster Session 3

• Examining Inadequate Response to Substance Use Disorder Treatment: A Scoping Review
  • Erminia Fardone, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Staff, poster presenter
  • Don L. Ekanayake, MSc, University of Miami Miller School of Medicine, CHERISH Methodology Core Staff, poster co-author
  • Kathryn E. McCollister, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Director, poster co-author
  • James McKay, PhD, University of Pennsylvania, CHERISH Advisory Board, poster-co-author
• Health and Economic Outcomes of Offering Buprenorphine in Shelters in Massachusetts: Results of a Simulation Model
  • Sabrina A. Assoumou, MD, MPH, Boston University School of Medicine, CHERISH Research Affiliate, poster co-author
  • Stavroula A. Chrysanthopoulou, PhD, MSc, BSc, Brown University, CHERISH Research Affiliate, poster co-author
  • Bruce R. Schackman, PhD, MBA, Weill Cornell Medicine, CHERISH Director, CHERISH Administrative Core Director, Population Data & Modeling Core Co-director, poster co-author
  • Benjamin P. Linas, MD, MPH, Boston Medical Center, CHERISH Population Data & Modeling Core Director, poster co-author
• Cost of a Group Technology-Based HIV and Sexually Transmitted Infection Prevention Intervention for Black Justice-Involved Women Who Use Drugs
  • Bruce R. Schackman, PhD, MBA, Weill Cornell Medicine, CHERISH Director, CHERISH Administrative Core Director, Population Data & Modeling Core Co-director, poster presenter
  • Laura Starbird, PhD, RN, University of Pennsylvania School of Nursing, CHERISH Research Affiliate, poster co-author
• The Association between State Cannabis Policies and Cannabis Use among Adults and Youth, United States, 2002-2019
  • Rosalie Pacula, PhD, University of Southern California, CHERISH Advisory Board, poster presenter
• The Proud Trial over 3 years: Impact of Massachusetts Model of Nurse Care Management for Office-Based Addiction Treatment on OUD Treatment in Primary Care
  • Jeffrey Samet, MD, MPH, MA, Boston University Chobanian and Avedisian School of Medicine, CHERISH Advisory Board, poster co-author
• Building Connection: Overdose Survivors’ and Professional Service Providers’ Recommendations for Improving Immediate Post-Overdose Care
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH Population Data & Modeling Core Investigator, poster co-author
• “You Can’t Incarcerate Yourself out of the Drug Problem in America:” The Burden of Additional Criminalization of Fentanyl
  • Joshua Barocas, MD, University of Colorado School of Medicine, CHERISH Research Affiliate, poster co-author
• Barriers and Facilitators to Mobile-Based Services Offered by Syringe Services Programs in New York State
  • Czarina Behrends, PhD, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, poster co-author
• Racial and Ethnic Disparities in Telehealth and Emergency Department Use among Women with Substance Use Disorder during the COVID-19 Pandemic
  • Sugy Choi, PhD, MS, NYU Grossman School of Medicine, CHERISH Research Affiliate, poster presenter
• Development and Validation of a Shorter Version of the PROMIS Quality of Life and Patient Preference Rating (PROPr) with People Coming out of County Jails with Opioid Use Disorders
  • Michael L. Dennis, PhD, Chestnut Health Systems, CHERISH Research Affiliate, poster presenter
• Assessing the Relationship between Body Mass Index and Substance Craving among Patients with Substance Use Disorder
  • Daniel J. Feaster, PhD, MS, University of Miami Miller School of Medicine, CHERISH Research Affiliate, poster co-author
• Concordance of Suspected, Self-reported Co-occurrence of Fentanyl with Other Drugs of Use and Urine Drug Testing among People Who Use Drugs in Rhode Island
  • Brandon Marshall, PhD, Brown University School of Public Health, CHERISH Research Affiliate, poster co-author
• Comparative Effectiveness of Buprenorphine/Naloxone Versus Methadone for Treatment of Opioid Use Disorder: Emulating Target Trials with Population-Level Data
  • Bohdan Nosyk, PhD, MA, Simon Fraser University, CHERISH Research Affiliate, poster presenter
• Comparative Effectiveness of Urine Drug Testing Schedules Alongside Opioid Agonist Treatment
  • Bohdan Nosyk, PhD, MA, Simon Fraser University, CHERISH Research Affiliate, poster co-author
• Harm Reduction and Substance Use Disorder Treatment Program Relations: Perspectives of Syringe Services Program Operators in Michigan
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, poster co-author
• Coverage and Management of Alcohol Use Disorder Treatment Services and Medications in Medicaid Managed Care Plans
  • Cindy P. Thomas, PhD, Brandeis University Heller School for Social Policy and Management, CHERISH Research Affiliate, poster co-author

↑ Back to Top